國立高雄大學圖資館 |

Language: English

Back

Resistance of cancer cells to CTL-me...

Bonavida, Benjamin.

Resistance of cancer cells to CTL-mediated immunotherapy

Record Type:	Electronic resources : Monograph/item
Title/Author:	Resistance of cancer cells to CTL-mediated immunotherapyedited by Benjamin Bonavida, Salem Chouaib.
other author:	Bonavida, Benjamin.
Published:	Cham :Springer International Publishing :2015.
Description:	xiv, 353 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Drug resistance in cancer cells.
Online resource:	http://dx.doi.org/10.1007/978-3-319-17807-3
ISBN:	9783319178073 (electronic bk.)

Resistance of cancer cells to CTL-mediated immunotherapy
Resistance of cancer cells to CTL-mediated immunotherapy[electronic resource] /edited by Benjamin Bonavida, Salem Chouaib. - Cham :Springer International Publishing :2015. - xiv, 353 p. :ill. (some col.), digital ;24 cm. - Resistance to targeted anti-cancer therapeutics,v.72196-5501 ;. - Resistance to targeted anti-cancer therapeutics ;v.4..

This book, written by leading investigators, brings together the latest knowledge about key aspects of the most rapidly progressing fields of tumor escape and tumor resistance to CTL. Readers will benefit from a collection of outstanding surveys that cover some factors regulating resistance to CTL cytotoxicity, the influence of tumor microenvironment, and the resistance to death ligands, mediated apoptosis, and means to reverse resistance. This remarkable volume also emphasizes the future directions that may lead to the design of more innovative, refined, and integrative immunotherapies to target tumor plasticity and heterogeneity, and help to overcome the inherent limitations of current treatments. By providing a broad scope of innovative concepts in the burgeoning field of cancer biology and immunotherapy, this volume will be of exceptional interest and a valuable reference for scientists, clinicians, health professionals, and biopharmaceutical companies working in the field of cancer immunotherapy.

ISBN: 9783319178073 (electronic bk.)

Standard No.: 10.1007/978-3-319-17807-3doiSubjects--Topical Terms:

281104
Drug resistance in cancer cells.

LC Class. No.: RC271.I45

Dewey Class. No.: 616.99406

Resistance of cancer cells to CTL-mediated immunotherapy
LDR:02063nmm a2200313 a 4500 001 471174
003 DE-He213
005 20160111144550.0
006 m d
007 cr nn 008maaau
008 160223s2015 gw s 0 eng d
020 $a 9783319178073 (electronic bk.)
020 $a 9783319178066 (paper)
024 7 $a 10.1007/978-3-319-17807-3 $2 doi
035 $a 978-3-319-17807-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC271.I45
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.99406 $2 23
090 $a RC271.I45 $b R433 2015
245 0 0 $a Resistance of cancer cells to CTL-mediated immunotherapy $h [electronic resource] / $c edited by Benjamin Bonavida, Salem Chouaib.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a xiv, 353 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Resistance to targeted anti-cancer therapeutics, $x 2196-5501 ; $v v.7
520 $a This book, written by leading investigators, brings together the latest knowledge about key aspects of the most rapidly progressing fields of tumor escape and tumor resistance to CTL. Readers will benefit from a collection of outstanding surveys that cover some factors regulating resistance to CTL cytotoxicity, the influence of tumor microenvironment, and the resistance to death ligands, mediated apoptosis, and means to reverse resistance. This remarkable volume also emphasizes the future directions that may lead to the design of more innovative, refined, and integrative immunotherapies to target tumor plasticity and heterogeneity, and help to overcome the inherent limitations of current treatments. By providing a broad scope of innovative concepts in the burgeoning field of cancer biology and immunotherapy, this volume will be of exceptional interest and a valuable reference for scientists, clinicians, health professionals, and biopharmaceutical companies working in the field of cancer immunotherapy.
650 0 $a Drug resistance in cancer cells. $3 281104
650 0 $a Cancer $x Immunotherapy. $3 201873
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Cancer Research. $3 273660
650 2 4 $a Drug Resistance. $3 338425
650 2 4 $a Molecular Medicine. $3 273932
700 1 $a Bonavida, Benjamin. $3 286298
700 1 $a Chouaib, Salem. $3 726228
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Resistance to targeted anti-cancer therapeutics ; $v v.4. $3 711051
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-17807-3
950 $a Biomedical and Life Sciences (Springer-11642)